Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Rachel K, Lim"'
Autor:
Maeve P. Smith, Heather Sharpe, Ronald W. Damant, Giovanni Ferrara, Rachel K. Lim, Michael K. Stickland, Grace Y. Lam
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Post-COVID-19 condition (PCC) is defined as the persistence of symptoms, like fatigue and dyspnea, at least 3 months post-COVID infection. As dyspnea is a common symptom, we attempted to further clinically phenotype those with PCC-associated
Externí odkaz:
https://doaj.org/article/901b51844d8a4ff28aaead8752e4558b
Autor:
Rohaid Ali, Ian D. Connolly, Oliver Y. Tang, Fatima N. Mirza, Benjamin Johnston, Hael F. Abdulrazeq, Rachel K. Lim, Paul F. Galamaga, Tiffany J. Libby, Neel R. Sodha, Michael W. Groff, Ziya L. Gokaslan, Albert E. Telfeian, John H. Shin, Wael F. Asaad, James Zou, Curtis E. Doberstein
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-6 (2024)
Abstract Despite the importance of informed consent in healthcare, the readability and specificity of consent forms often impede patients’ comprehension. This study investigates the use of GPT-4 to simplify surgical consent forms and introduces an
Externí odkaz:
https://doaj.org/article/6ac331ae728a4e08b70ef37ec85b97d3
Autor:
Rohaid Ali, Ian D. Connolly, Oliver Y. Tang, Fatima N. Mirza, Benjamin Johnston, Hael F. Abdulrazeq, Rachel K. Lim, Paul F. Galamaga, Tiffany J. Libby, Neel R. Sodha, Michael W. Groff, Ziya L. Gokaslan, Albert E. Telfeian, John H. Shin, Wael F. Asaad, James Zou, Curtis E. Doberstein
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/1699e5bd999f4a44bacb72aecd78bdae
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
COVID-19 can have detrimental effects on immunosuppressed patients. Here, we evaluate the evidence regarding continuing immunomodulatory/biologic (IMBI) therapy in pregnant dermatology patients during the COVID-19 pandemic. Also, we discuss the risks
Externí odkaz:
https://doaj.org/article/828d6f076d9a45c1b0a9716d4f9edb8a
Autor:
Rachel K. Lim, Ryan Rosentreter, Yushi Chen, Rahul Mehta, Graham McLeod, Miranda Wan, Jonathan D. Krett, Yasamin Mahjoub, Angela Lee, Ilan Schwartz, Luanne Metz, Lawrence Richer, Eric Smith, Michael D. Hill, ALBERTA HOPE COVID-19 Collaborators, Aravind Ganesh
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-4 (2022)
Abstract The long-term impact of COVID-19 among those with mild infections is not well characterized. Among 81 adults who completed online assessments at 3- and 12-months following infection, quality of life scores did not significantly improve over
Externí odkaz:
https://doaj.org/article/068e702f7e7041bc933a81d3057eb595
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The burden of hospitalizations and mortality for hemoptysis due to bronchiectasis is not well characterized. The primary outcome of our study was to evaluate in-hospital mortality in patients admitted with hemoptysis and bronchiec
Externí odkaz:
https://doaj.org/article/50581feff1364b928b5ec6550e804f69
Autor:
Rachel K. Lim, BA, Saisanjana Kalagara, MD, Kenneth K. Chen, MD, Eleftherios Mylonakis, MD, George Kroumpouzos, MD, PhD
Publikováno v:
International Journal of Women's Dermatology, Vol 7, Iss 5, Pp 640-646 (2021)
The care for patients infected with COVID-19 requires a team approach, and dermatologists may collaborate with other specialties, especially infectious disease (ID) medicine and obstetrics and gynecology (ObGyn), at every stage of the infection proce
Externí odkaz:
https://doaj.org/article/0e122efd3cba4a5099375b02c52e0f20
Publikováno v:
ERJ Open Research, Vol 8, Iss 4 (2022)
Non-cystic fibrosis bronchiectasis (NCFB) is a highly prevalent chronic respiratory disease with substantial burden to both patients and healthcare systems. Persons with NCFB (pwNCFB) are often given complex acute and chronic treatment regimens consi
Externí odkaz:
https://doaj.org/article/4ad6ca893b2b4b4d9af095d9c144a139
Autor:
Rachel K Lim, Fred C Semitala, Elly Atuhumuza, Laban Sabiti, Jane Namakula-Katende, Winnie R Muyindike, Moses R Kamya, David Dowdy, Adithya Cattamanchi
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246113 (2021)
A 12-dose weekly regimen of rifapentine plus isoniazid (3HP) is recommended for the prevention of active tuberculosis (TB); however, it is unclear whether 3HP should be provided by directly observed therapy (DOT) or self-administered therapy (SAT). I
Externí odkaz:
https://doaj.org/article/49183bb919474579bb1837cc44e17745
Autor:
Rachel K. Lim, Martin A. Weinstock
Publikováno v:
Journal of the American Academy of Dermatology.